In-vitro Toxicology Testing Market

In-vitro Toxicology Testing Market by Technologies [Cell Culture, Molecular Imaging, High throughput, and OMICS], Types [Toxic Substances, Dose, and Absorption], Applications [Cytotoxicity, Neuro Toxicity, and Dermal Toxicity], End-users [Food Industry, Cosmetic and Household Products, Chemical Industry, Pharmaceuticals Industry, and Others], and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1070
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The in-vitro toxicology testing market size was valued at USD 9.1 billion in 2020 and is anticipated to expand at significant CAGR during forecast period 2021–2028. Growth of the market is attributed to increasing population, increased global illicit drug abusers, advancement in genetics, and enhanced efficiency of in-vitro toxicology testing in diagnosis of cancer.
 

In-vitro Toxicology Testing Market Key Takeaways


In-vitro toxicity testing is the scientific method of finding the effects of toxic chemical compounds on mammalian cells and cultured bacteria. In-vitro testing done in a laboratory generally contains animal cells, micro-organism, and human cells in culture. This system of analysis allows scientists to asses’ different biological singularities in specific cells without the interruptions and potential confusing.

The Covid-19 pandemic affected the demand and supply of in-vitro toxicology testing market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

  • Rapid advancement in genetics is projected to boost the market in the coming years.
  • Increasing awareness about environmental concerns is the major factor fueling the market in coming years.
  • Decrease in adaptation rate of in-vitro toxicology testing is anticipated to restrict the market growth.
  • Incapability of in-vitro toxicology testing to detect toxicity is projected to hamper the market expansion.
  • R&D investment and technological advancement in in-vitro toxicology testing is projected to create lucrative opportunities for the market players.

Scope of the Report

The report on the in-vitro toxicology testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

In-vitro Toxicology Testing Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018-2019

Forecast Period

2021-2028

Segmentation

Technologies [Cell Culture, Molecular Imaging, High throughput, and OMICS], Types [Toxic Substances, Dose, and Absorption], Applications [Cytotoxicity, Neuro Toxicity, and Dermal Toxicity], End-users [Food Industry, Cosmetic and Household Products, Chemical Industry, Pharmaceuticals Industry, and Others]

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East &

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Agilent Technologies, Inc., BioReliance, Inc., Abbott Laboratories, Covance, Inc., Eurofins Scientific, Agilent Technologies, Bio-Rad Laboratories, Alere, Inc., Thermo Fisher Scientific, Inc., Accelrys, Inc., MatTek Corporation, Catalent, Inc., Xenometrix AG, Quest Diagnostics Incorporation, and Charles River Laboratories International, Inc.

 

Market Segment Insights

The cosmetic and household products accounts for key share of the market
Based on end-users, the in-vitro toxicology testing market is segregated into food industry, cosmetic and household products, chemical industry, pharmaceuticals industry, and others. The cosmetic and household products segment is projected to expand at a rapid pace during the forecast period. Growth of the market is attributed to the increasing population, advancement in genetics, and enhanced efficiency of in-vitro toxicology testing in diagnosis of cancer. However, the pharmaceuticals industry segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing R&D procedures, ban on animal testing, and stringent government regulations towards environment.

The cell culture segment accounts for a significant share of the market
On the basis of technologies, the in-vitro toxicology testing market is segmented into cell culture, molecular imaging, high throughput, and OMICS. The cell culture segment accounts for a key share of the market. Growth of the market is attributed to rising population, ban on animal testing, and stringent government regulations towards environment.

The toxic substances segment is anticipated to grow at rapid peace
Based on types, the in-vitro toxicology testing market is divided into toxic substances, dose, and absorption. The toxic substances segment accounts for a key share of the market. Growth of the market is attributed to increasing demand of in-vitro toxicology testing in pharmaceuticals sector and increasing advancement in genetics. The absorption segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increased global illicit drug abusers and rapid technological advancement in in-vitro toxicology testing method.
 

In-vitro Toxicology Testing Market By Types


The neuro toxicity segment is expected to expand at a rapid pace during the forecast period
On the basis of applications, the in-vitro toxicology testing market is segmented into cytotoxicity, neuro toxicity, and dermal toxicity. The neuro toxicity segment holds the major market share. Neuro toxicity is obtained when the body exposes to human made and natural toxic compounds. This compound changes the general activity of the nervous system. The dermal toxicity is the capacity of a compound to cause systemic poisoning and general reaction in animals and human, when it comes in contact with the skin.

The market in North America is projected to dominate the market
On the basis of regions, the in-vitro toxicology testing market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is projected to dominate the market due to increase in number of R&D procedures, ban on animal testing, and stringent government regulations towards environment. The market in Asia Pacific is anticipated to expand at high CAGR during forecast period due to factors increased global illicit drug abusers and rapid technological advancement in in-vitro toxicology testing method.
 

In-vitro Toxicology Testing Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In-vitro Toxicology Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. In-vitro Toxicology Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. In-vitro Toxicology Testing Market - Supply Chain
  4.5. Global In-vitro Toxicology Testing Market Forecast
     4.5.1. In-vitro Toxicology Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. In-vitro Toxicology Testing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. In-vitro Toxicology Testing Market Absolute $ Opportunity
5. Global In-vitro Toxicology Testing Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. In-vitro Toxicology Testing Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global In-vitro Toxicology Testing Demand Share Forecast, 2019-2026
6. North America In-vitro Toxicology Testing Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America In-vitro Toxicology Testing Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America In-vitro Toxicology Testing Demand Share Forecast, 2019-2026
7. Latin America In-vitro Toxicology Testing Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America In-vitro Toxicology Testing Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America In-vitro Toxicology Testing Demand Share Forecast, 2019-2026
8. Europe In-vitro Toxicology Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe In-vitro Toxicology Testing Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe In-vitro Toxicology Testing Demand Share Forecast, 2019-2026
9. Asia Pacific In-vitro Toxicology Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific In-vitro Toxicology Testing Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific In-vitro Toxicology Testing Demand Share Forecast, 2019-2026
10. Middle East & Africa In-vitro Toxicology Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa In-vitro Toxicology Testing Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa In-vitro Toxicology Testing Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global In-vitro Toxicology Testing Market: Market Share Analysis
  11.2. In-vitro Toxicology Testing Distributors and Customers
  11.3. In-vitro Toxicology Testing Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Agilent Technologies, Inc.
     11.4.2. BioReliance, Inc.
     11.4.3. Abbott Laboratories
     11.4.4. Covance, Inc.
     11.4.5. Eurofins Scientific

Segments Covered in the Report
The in-vitro toxicology testing market has been segmented on the basis of

Technologies

  • Cell Culture
  • Molecular Imaging
  • High throughput
  • OMICS

Types

  • Toxic Substances
  • Dose
  • Absorption

Applications

  • Cytotoxicity
  • Neuro Toxicity
  • Dermal Toxicity

End-users

  • Food Industry
  • Cosmetic and Household Products
  • Chemical Industry
  • Pharmaceuticals Industry
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Agilent Technologies, Inc.
  • BioReliance, Inc.
  • Abbott Laboratories
  • Covance, Inc.
  • Eurofins Scientific
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Alere, Inc.
  • Thermo Fisher Scientific, Inc.
  • Accelrys, Inc.
  • MatTek Corporation
  • Catalent, Inc.
  • Xenometrix AG
  • Quest Diagnostics Incorporation
  • Charles River Laboratories International, Inc.

Key players competing in the in-vitro toxicology testing market include Agilent Technologies, Inc., BioReliance, Inc., Abbott Laboratories, Covance, Inc., Eurofins Scientific, Agilent Technologies, Bio-Rad Laboratories, Alere, Inc., Thermo Fisher Scientific, Inc., Accelrys, Inc., MatTek Corporation, Catalent, Inc., Xenometrix AG, Quest Diagnostics Incorporation, and Charles River Laboratories International, Inc.

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming year.
 

In-vitro Toxicology Testing Market By Key Players

Buy Report